Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
This trial is active, not recruiting.
|Condition||head and neck neoplasms|
|Sponsor||Technische Universität Dresden|
|Start date||July 2006|
|End date||August 2018|
|Trial size||60 participants|
|Trial identifier||NCT00180180, HNO-FMISO-FU|
The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy
Male or female participants from 18 years up to 70 years old.
Inclusion Criteria: - histologically confirmed head-and-neck cancer not curable by surgery - Karnofsky > 70% - tumor volume and localisation allow curative radiotherapy - written consent Exclusion Criteria: - metastases - earlier radiation therapy of head and neck - pregnancy - secondary malignancy excluding dermal carcinoma and Tis-carcinoma of cervix uteri - psychiatric impairment
|Official title||Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO|
|Principal investigator||Joerg Kotzerke, MD|
Call for more information